본문 바로가기
KERD
논문KCI 등재

A multicenter study of interobserver variability in pathologic diagnosis of papillary breast lesions on core needle biopsy with WHO classification

0

조회

0

다운로드

0

인용

0

참고문헌

키워드

주제분류병리학

초록

Background: Papillary breast lesions (PBLs) comprise diverse entities from benign and atypical lesions to malignant tumors. Although PBLs are characterized by a papillary growth pattern, it is challenging to achieve high diagnostic accuracy and reproducibility. Thus, we investigated the diagnostic reproducibility of PBLs in core needle biopsy (CNB) specimens with World Health Organization (WHO) classification.Methods: Diagnostic reproducibility was assessed using interobserver variability (kappa value, κ) and agreement rate in the pathologic diagnosis of 60 PBL cases on CNB among 20 breast pathologists affiliated with 20 medical institutions in Korea. This analysis was performed using hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining for cytokeratin 5 (CK5) and p63. The pathologic diagnosis of PBLs was based on WHO classification, which was used to establish simple classifications (4-tier, 3-tier, and 2-tier). Results: On WHO classification, H&E staining exhibited ‘fair agreement’ (κ = 0.21) with a 47.0% agreement rate. Simple classifications presented improvement in interobserver variability and agreement rate. IHC staining increased the kappa value and agreement rate in all the classifications. Despite IHC staining, the encapsulated/solid papillary carcinoma (EPC/SPC) subgroup (κ = 0.16) exhibited lower agreement compared to the non-EPC/SPC subgroup (κ = 0.35) with WHO classification, which was similar to the results of any other classification systems. Conclusions: Although the use of IHC staining for CK5 and p63 increased the diagnostic agreement of PBLs in CNB specimens, WHO classification exhibited a higher discordance rate compared to any other classifications. Therefore, this result warrants further intensive consensus studies to improve the diagnostic reproducibility of PBLs with WHO classification.

Abstract

Background: Papillary breast lesions (PBLs) comprise diverse entities from benign and atypical lesions to malignant tumors. Although PBLs are characterized by a papillary growth pattern, it is challenging to achieve high diagnostic accuracy and reproducibility. Thus, we investigated the diagnostic reproducibility of PBLs in core needle biopsy (CNB) specimens with World Health Organization (WHO) classification.Methods: Diagnostic reproducibility was assessed using interobserver variability (kappa value, κ) and agreement rate in the pathologic diagnosis of 60 PBL cases on CNB among 20 breast pathologists affiliated with 20 medical institutions in Korea. This analysis was performed using hematoxylin and eosin (H&E) staining and immunohistochemical (IHC) staining for cytokeratin 5 (CK5) and p63. The pathologic diagnosis of PBLs was based on WHO classification, which was used to establish simple classifications (4-tier, 3-tier, and 2-tier). Results: On WHO classification, H&E staining exhibited ‘fair agreement’ (κ = 0.21) with a 47.0% agreement rate. Simple classifications presented improvement in interobserver variability and agreement rate. IHC staining increased the kappa value and agreement rate in all the classifications. Despite IHC staining, the encapsulated/solid papillary carcinoma (EPC/SPC) subgroup (κ = 0.16) exhibited lower agreement compared to the non-EPC/SPC subgroup (κ = 0.35) with WHO classification, which was similar to the results of any other classification systems. Conclusions: Although the use of IHC staining for CK5 and p63 increased the diagnostic agreement of PBLs in CNB specimens, WHO classification exhibited a higher discordance rate compared to any other classifications. Therefore, this result warrants further intensive consensus studies to improve the diagnostic reproducibility of PBLs with WHO classification.

참고문헌 (28)

  1. Tay TK, "Papillary neoplasms of the breast : reviewing the spectrum", Mod Pathol, 34, pp.1044~1061 (2021)
  2. Jorns JM, "Papillary lesions of the breast : a practical approach to diagnosis", Arch Pathol Lab Med, 140, pp.1052~1059 (2016)
  3. Ni YB, "Pathological criteria and practical issues in papillary lesions of the breast : a review", Histopathology, 68, pp.22~32 (2016)
  4. Lewis JT, "An analysis of breast cancer risk in women with single, multiple, and atypical papilloma", Am J Surg Pathol, 30, pp.665~672 (2006)
  5. Louwman MW, "Uncommon breast tumors in perspective : incidence, treatment and survival in the Netherlands", Int J Cancer, 121, pp.127~135 (2007)
  6. Yamaguchi R, "Management of breast papillary lesions diagnosed in ultrasound-guided vacuum-assisted and core needle biopsies", Histopathology, 66, pp.565~576 (2015)
  7. Moon SM, "Management of clinically and mammographically occult benign papillary lesions diagnosed at ultrasound-guided 14-gauge breast core needle biopsy", J Ultrasound Med, 35, pp.2325~2332 (2016)
  8. Brogi E, "WHO classification of breast tumors", pp.49~67 (2019), International Agency for Research on Cancer
  9. O’Malley F, "WHO classification of tumours of the breast", pp.99~109 (2012), International Agency for Research on Cancer
  10. Rakha EA, "Diagnostic challenges in papillary lesions of the breast", Pathology, 50, pp.100~110 (2018)
  11. Qiu L, "Diagnosis of papillary breast lesions on core needle biopsy : upgrade rates and interobserver variability", Int J Surg Pathol, 27, pp.736~743 (2019)
  12. Douglas-Jones A, "Observer variability in the histopathological reporting of core biopsies of papillary breast lesions is reduced by the use of immunohistochemistry for CK5", 6, calponin and p63, 2005, pp.47, 202~208
  13. Jakate K, "Papillary lesions of the breast : impact of breast pathology subspecialization on core biopsy and excision diagnoses", Am J Surg Pathol, 36, pp.544~551 (2012)
  14. Ellis IO, "Best Practice No 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment", J Clin Pathol, 57, pp.897~902 (2004)
  15. Elmore JG, "Diagnostic concordance among pathologists interpreting breast biopsy specimens", JAMA, 313, pp.1122~1132 (2015)
  16. Koo JS, "Can additional immunohistochemistry staining replace the surgical excision for the diagnosis of papillary breast lesions classified as benign on 14-gage core needle biopsy?", Breast Cancer Res Treat, 137, pp.797~806 (2013)
  17. Boecker W, "Usual ductal hyperplasia of the breast is a committed stem(progenitor)cell lesion distinct from atypical ductal hyperplasia and ductal carcinoma in situ", J Pathol, 198, pp.458~467 (2002)
  18. Otterbach F, "Cytokeratin 5", 6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast, 2000, pp.37, 232~240
  19. Lerwill MF, "Current practical applications of diagnostic immunohistochemistry in breast pathology", Am J Surg Pathol, 28, pp.1076~1091 (2004)
  20. Hoda SA, "Practical considerations in the pathologic diagnosis of needle core biopsies of breast", Am J Clin Pathol, 118, pp.101~108 (2002)
  21. Collins LC, "Intracystic papillary carcinomas of the breast : a reevaluation using a panel of myoepithelial cell markers", Am J Surg Pathol, 30, pp.1002~1007 (2006)
  22. Cui X, "Composite encapsulated papillary carcinoma and solid papillary carcinoma", Pathol Int, 65, pp.133~137 (2015)
  23. Hashmi AA, "Spectrum of papillary breast lesions according to World Health Organization classification of papillary neoplasms of breast", Cureus, 12, pp.e11026~ (2020)
  24. Agoumi M, "Practical considerations in breast papillary lesions : a review of the literature", Arch Pathol Lab Med, 140, pp.770~790 (2016)
  25. Feinstein AR, "High agreement but low kappa: I. The problems of two paradoxes", J Clin Epidemiol, 43, pp.543~549 (1990)
  26. Tramm T, "Diminished number or complete loss of myoepithelial cells associated with metaplastic and neoplastic apocrine lesions of the breast", Am J Surg Pathol, 35, pp.202~211 (2011)
  27. Cserni G, "Benign apocrine papillary lesions of the breast lacking or virtually lacking myoepithelial cells-potential pitfalls in diagnosing malignancy", APMIS, 120, pp.249~252 (2012)
  28. Wei S, "Papillary lesions of the breast : an update", Arch Pathol Lab Med, 140, pp.628~643 (2016)

관련 논문AI추천

What’s new in breast pathology 2022: WHO 5th edition and biomarker updatesGary Tozbikian, Julie M. Jorns, Kristen Muller대한병리학회 · Journal of Pathology and Translational Medicine2022 · 제56권 제3호Excision Can Be Delayed until Size Grows in Small Papillary Lesions of the BreastIsaac Kim, Jae Young Jang, Seung Ah Lee, Seung Ki Kim한국유방암학회 · Journal of Breast Disease2020 · 제8권 제1호The Ratio of Atypical Ductal Hyperplasia Foci to Core Numbers in Needle Biopsy: A Practical Index Predicting Breast Cancer in Subsequent Excision강준, 공경엽, 이정주, 이희진, 조정현대한병리학회 · Journal of Pathology and Translational Medicine2012 · 제46권 제1호Clinicopathologic Features of Pleomorphic Invasive Lobular Carcinoma: Comparison with Classic Invasive Lobular CarcinomaChangho Yeom, Hyosun Kim, Sun Hee Kang, Sunyoung Kwon한국유방암학회 · Journal of Breast Disease2016 · 제4권 제1호Interobserver Variability of Ki-67 Measurement in Breast Cancer공경엽, 박소연, 이지신, 장민혜, 정우희, 정율리, The Korean Breast Pathology Ki-67 Study Group대한병리학회 · Journal of Pathology and Translational Medicine2016 · 제50권 제2호Analysis of the molecular subtypes of preoperative core needle biopsy and surgical specimens in invasive breast cancer강준, 김성훈, 이아원, 이지은, 정예슬, YOO TAE KYUNG R대한병리학회 · Journal of Pathology and Translational Medicine2020 · 제54권 제1호

이 간행물의 다른 논문 (8건)